Zobrazeno 1 - 10
of 17
pro vyhledávání: '"inhibitory tyrosinkinas"'
Autor:
Slobodníková, Eva
Cabozantinib is an anti-cancer drug used mainly for the treatment of thyroid and renal cell carcinoma. It is classified as a low molecular weight selective tyrosine kinase inhibitor. Tyrosine kinases play a key role in signal transduction and regulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::80e885aa421b521ef2dc0244bfddc53d
http://www.nusl.cz/ntk/nusl-527892
http://www.nusl.cz/ntk/nusl-527892
Autor:
Rodová, Marie
1 Abstract Recently, biologically targeted treatment by another name targeted molecular therapies have begun to be used in the treatment of cancers bearing specific molecular genetic or morphological traits. Vandetanib is an oral anticancer drug that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::7dce849816443b74246245944515eeab
http://www.nusl.cz/ntk/nusl-451361
http://www.nusl.cz/ntk/nusl-451361
Autor:
Měkotová, Barbora
In recent years, tyrosine kinase inhibitors have been more and more used for the targeted cancer therapy, due to their ability to disrupt intracellular signalling pathways associated with the development of tumours. Cabozantinib is the tyrosine kinas
Externí odkaz:
http://www.nusl.cz/ntk/nusl-434086
Autor:
Měkotová, Barbora
In recent years, tyrosine kinase inhibitors have been more and more used for the targeted cancer therapy, due to their ability to disrupt intracellular signalling pathways associated with the development of tumours. Cabozantinib is the tyrosine kinas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::9a85b156874fac672b5a778cef53936f
http://www.nusl.cz/ntk/nusl-434086
http://www.nusl.cz/ntk/nusl-434086
Autor:
Uher, Tomáš
Targeted therapies, acting by blocking essential biochemical pathways required for tumor cell growth and survival, are being used lately in multiple cases of cancer treatment. Cabozantinib, a small molecule inhibitor of receptor tyrosine kinases, is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::a7e34466c8ffc9cbadfda9d1657a175c
http://www.nusl.cz/ntk/nusl-435186
http://www.nusl.cz/ntk/nusl-435186
Autor:
Takácsová, Paulína
Tyrosine kinase inhibitors (TKI) are small organic molecules designed for the targeted cancer therapy. They perform the inhibition of activated receptor tyrosine kinases in tumor cells, that defeats tumor growth, proliferation, metastasis and angioge
Externí odkaz:
http://www.nusl.cz/ntk/nusl-397009
Autor:
Baráčková, Petra
In recent years, tyrosine kinase inhibitors have been widely used for the treatment of certain tumors as so-called targeted therapy. Many studies are concerned with their metabolism and the role of enzymes in the biotransformation process, but very l
Externí odkaz:
http://www.nusl.cz/ntk/nusl-396681
Autor:
Takácsová, Paulína
Tyrosine kinase inhibitors (TKI) are small organic molecules designed for the targeted cancer therapy. They perform the inhibition of activated receptor tyrosine kinases in tumor cells, that defeats tumor growth, proliferation, metastasis and angioge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::004f991deda5fd34608950c97414016e
http://www.nusl.cz/ntk/nusl-397009
http://www.nusl.cz/ntk/nusl-397009
Autor:
Baráčková, Petra
In recent years, tyrosine kinase inhibitors have been widely used for the treatment of certain tumors as so-called targeted therapy. Many studies are concerned with their metabolism and the role of enzymes in the biotransformation process, but very l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::59b973e58beaf08b75587a62a1da34f5
http://www.nusl.cz/ntk/nusl-396681
http://www.nusl.cz/ntk/nusl-396681
Autor:
Jelínková, Sandra
In recent years, the inhibiition of tyrosine kinases,which may incorrectly regulate some singaling pathway has been used to treat cancer as so-called biological therapy. An example of such inhibitors are vandetanib and lenvatinib. These two substance
Externí odkaz:
http://www.nusl.cz/ntk/nusl-379348